These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 10966281

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension.
    Deb B, Bradford K, Pearl RG.
    Crit Care Med; 2000 Mar; 28(3):795-9. PubMed ID: 10752832
    [Abstract] [Full Text] [Related]

  • 3. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension.
    Curran RD, Mavroudis C, Backer CL, Sautel M, Zales VR, Wessel DL.
    Ann Thorac Surg; 1995 Dec; 60(6):1765-71. PubMed ID: 8787478
    [Abstract] [Full Text] [Related]

  • 4. Inhaled nitric oxide versus sodium nitroprusside for preoperative evaluation of pulmonary hypertension in heart transplant candidates.
    Pasero D, Rana NK, Bonato R, Ribezzo M, Ivaldi F, Ricci D, Grosso Marra W, Checco L, Lupo M, Boffini M, Rinaldi M.
    Transplant Proc; 2013 Sep; 45(7):2746-9. PubMed ID: 24034038
    [Abstract] [Full Text] [Related]

  • 5. Use of inhaled iloprost for the management of postoperative pulmonary hypertension in congenital heart surgery patients: review of a transition protocol.
    Vorhies EE, Caruthers RL, Rosenberg H, Yu S, Gajarski RJ.
    Pediatr Cardiol; 2014 Dec; 35(8):1337-43. PubMed ID: 24872141
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of inhaled iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: a prospective randomized trial.
    Winterhalter M, Simon A, Fischer S, Rahe-Meyer N, Chamtzidou N, Hecker H, Zuk J, Piepenbrock S, Strüber M.
    J Cardiothorac Vasc Anesth; 2008 Jun; 22(3):406-13. PubMed ID: 18503929
    [Abstract] [Full Text] [Related]

  • 8. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects.
    Journois D, Pouard P, Mauriat P, Malhère T, Vouhé P, Safran D.
    J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1129-35. PubMed ID: 8159035
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vasodilator testing with nitric oxide and/or oxygen in pediatric pulmonary hypertension.
    Barst RJ, Agnoletti G, Fraisse A, Baldassarre J, Wessel DL, NO Diagnostic Study Group.
    Pediatr Cardiol; 2010 Jul; 31(5):598-606. PubMed ID: 20405117
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.
    Ziegler JW, Ivy DD, Wiggins JW, Kinsella JP, Clarke WR, Abman SH.
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1388-95. PubMed ID: 9817684
    [Abstract] [Full Text] [Related]

  • 14. Inhaled nitric oxide in infants and children after open heart surgery.
    Zobel G, Gamillscheg A, Schwinger W, Berger J, Urlesberger B, Dacar D, Rigler B, Metzler H, Beitzke A.
    J Cardiovasc Surg (Torino); 1998 Feb; 39(1):79-86. PubMed ID: 9537540
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease.
    Bizzarro M, Gross I, Barbosa FT.
    Cochrane Database Syst Rev; 2014 Jul 03; 2014(7):CD005055. PubMed ID: 24991723
    [Abstract] [Full Text] [Related]

  • 18. Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease.
    Ivy DD, Kinsella JP, Ziegler JW, Abman SH.
    J Thorac Cardiovasc Surg; 1998 Apr 03; 115(4):875-82. PubMed ID: 9576224
    [Abstract] [Full Text] [Related]

  • 19. Inhaled nitric oxide results in deteriorating hemodynamics when administered during cardiopulmonary bypass in neonatal swine.
    Hubble CL, Cheifetz IM, Craig DM, Quick G, Meliones JN, Clark RH.
    Pediatr Crit Care Med; 2004 Mar 03; 5(2):157-62. PubMed ID: 14987346
    [Abstract] [Full Text] [Related]

  • 20. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease.
    Bizzarro M, Gross I.
    Cochrane Database Syst Rev; 2005 Oct 19; (4):CD005055. PubMed ID: 16235391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.